請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/30715完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 蘇銘嘉(Ming-Jai Su) | |
| dc.contributor.author | Long-Sheng Lu | en |
| dc.contributor.author | 呂隆昇 | zh_TW |
| dc.date.accessioned | 2021-06-13T02:13:16Z | - |
| dc.date.available | 2008-07-10 | |
| dc.date.copyright | 2007-07-10 | |
| dc.date.issued | 2007 | |
| dc.date.submitted | 2007-06-05 | |
| dc.identifier.citation | 1. Goldstein JL, DeBose-Boyd RA, Brown MS. Protein sensors for membrane sterols. Cell. 2006;124(1):35-46.
2. Devries-Seimon T, Li Y, Yao PM, Stone E, Wang Y, Davis RJ, Flavell R, Tabas I. Cholesterol-induced macrophage apoptosis requires ER stress pathways and engagement of the type A scavenger receptor. J Cell Biol. 2005;171(1):61-73. 3. Benninger RK, Onfelt B, Neil MA, Davis DM, French PM. Fluorescence imaging of two-photon linear dichroism: cholesterol depletion disrupts molecular orientation in cell membranes. Biophys J. 2005;88(1):609-622. 4. Shogomori H, Futerman AH. Cholesterol depletion by methyl-beta-cyclodextrin blocks cholera toxin transport from endosomes to the Golgi apparatus in hippocampal neurons. J Neurochem. 2001;78(5):991-999. 5. Kabouridis PS, Janzen J, Magee AL, Ley SC. Cholesterol depletion disrupts lipid rafts and modulates the activity of multiple signaling pathways in T lymphocytes. Eur J Immunol. 2000;30(3):954-963. 6. Spady DK, Woollett LA, Dietschy JM. Regulation of plasma LDL-cholesterol levels by dietary cholesterol and fatty acids. Annu Rev Nutr. 1993;13:355-381. 7. Endo A, Kuroda M, Tanzawa K. Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity. FEBS Lett. 1976;72(2):323-326. 8. Repa JJ, Turley SD, Quan G, Dietschy JM. Delineation of molecular changes in intrahepatic cholesterol metabolism resulting from diminished cholesterol absorption. J Lipid Res. 2005;46(4):779-789. 9. Ross R, Glomset J, Harker L. Response to injury and atherogenesis. Am J Pathol. 1977;86(3):675-684. 10. Madamanchi NR, Vendrov A, Runge MS. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol. 2005;25(1):29-38. 11. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. Jama. 2007;297(8):842-857. 12. Kris-Etherton PM, Lichtenstein AH, Howard BV, Steinberg D, Witztum JL. Antioxidant vitamin supplements and cardiovascular disease. Circulation. 2004;110(5):637-641. 13. Stokes KY, Cooper D, Tailor A, Granger DN. Hypercholesterolemia promotes inflammation and microvascular dysfunction: role of nitric oxide and superoxide. Free Radic Biol Med. 2002;33(8):1026-1036. 14. Stokes KY, Granger DN. The microcirculation: a motor for the systemic inflammatory response and large vessel disease induced by hypercholesterolaemia? J Physiol. 2005;562(Pt 3):647-653. 15. Tilton RG, Cole PA, Zions JD, Daugherty A, Larson KB, Sutera SP, Kilo C, Williamson JR. Increased ischemia-reperfusion injury to the heart associated with short-term, diet-induced hypercholesterolemia in rabbits. Circ Res. 1987;60(4):551-559. 16. Chen MF, Lee YT, Hsu HC, Yeh PC, Liau CS, Huang PC. Effects of dietary supplementation with fish oil on atherosclerosis and myocardial injury during acute coronary occlusion-reperfusion in diet-induced hypercholesterolemic rabbits. Int J Cardiol. 1992;35(3):323-331. 17. Jerosch-Herold M, Wilke N, Stillman AE. Magnetic resonance quantification of the myocardial perfusion reserve with a Fermi function model for constrained deconvolution. Med Phys. 1998;25(1):73-84. 18. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, Larsson HB, Lee TY, Mayr NA, Parker GJ, Port RE, Taylor J, Weisskoff RM. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging. 1999;10(3):223-232. 19. Blumlein S, Sievers R, Wikman-Coffelt J, Parmley WW. Lack of decreased contractility in hearts from atherosclerotic rabbits. Am Heart J. 1983;106(6):1383-1388. 20. Schwemmer M, Sommer O, Bassenge E. Blockade of angiotensin signaling improves myocardial function in hypercholesterolemia independent of changes in eicosanoid release. Cardiovasc Drugs Ther. 2000;14(3):317-327. 21. Yeh YF, Huang SL. Enhancing effect of dietary cholesterol and inhibitory effect of pravastatin on allergic pulmonary inflammation. J Biomed Sci. 2004;11(5):599-606. 22. Teufelhofer O, Parzefall W, Kainzbauer E, Ferk F, Freiler C, Knasmuller S, Elbling L, Thurman R, Schulte-Hermann R. Superoxide generation from Kupffer cells contributes to hepatocarcinogenesis: studies on NADPH oxidase knockout mice. Carcinogenesis. 2005;26(2):319-329. 23. Deng JY, Huang JP, Lu LS, Hung LM. Impairment of cardiac insulin signaling and myocardial contractile performance in high cholesterol-fructose fed rats. Am J Physiol Heart Circ Physiol. Mar 30. 2007. Online early article 24. Luo TY, Wu CC, Liu YB, Fu YK, Su MJ. Dietary cholesterol affects sympathetic nerve function in rabbit hearts. J Biomed Sci. 2004;11(3):339-345. 25. Rodriguez-Porcel M, Lerman A, Ritman EL, Wilson SH, Best PJ, Lerman LO. Altered myocardial microvascular 3D architecture in experimental hypercholesterolemia. Circulation. 2000;102(17):2028-2030. 26. Pietzsch J, Bergmann R, Wuest F, Pawelke B, Hultsch C, van den Hoff J. Catabolism of native and oxidized low density lipoproteins: in vivo insights from small animal positron emission tomography studies. Amino Acids. 2005;29(4):389-404. 27. Liu K, Pierce GN. The effects of low density lipoprotein on calcium transients in isolated rabbit cardiomyocytes. J Biol Chem. 1993;268(5):3767-3775. 28. Iwai-Kanai E, Hasegawa K, Sawamura T, Fujita M, Yanazume T, Toyokuni S, Adachi S, Kihara Y, Sasayama S. Activation of lectin-like oxidized low-density lipoprotein receptor-1 induces apoptosis in cultured neonatal rat cardiac myocytes. Circulation. 2001;104(24):2948-2954. 29. Carlson SE, Goldfarb S. A sensitive enzymatic method for determination of free and esterified tissue cholesterol. Clin Chim Acta. 1977;79(3):575-582. 30. Kruger C, Kalenka A, Haunstetter A, Schweizer M, Maier C, Ruhle U, Ehmke H, Kubler W, Haass M. Baroreflex sensitivity and heart rate variability in conscious rats with myocardial infarction. Am J Physiol. 1997;273(5 Pt 2):H2240-2247. 31. Zimmerman MC, Davisson RL. Redox signaling in central neural regulation of cardiovascular function. Prog Biophys Mol Biol. 2004;84(2-3):125-149. 32. Liu X, Hawkes E, Ishimaru T, Tran T, Sretavan DW. EphB3: an endogenous mediator of adult axonal plasticity and regrowth after CNS injury. J Neurosci. 2006;26(12):3087-3101. 33. Xie WR, Deng H, Li H, Bowen TL, Strong JA, Zhang JM. Robust increase of cutaneous sensitivity, cytokine production and sympathetic sprouting in rats with localized inflammatory irritation of the spinal ganglia. Neuroscience. 2006;142(3):809-822. 34. Aso Y, Wakabayashi S, Nakano T, Yamamoto R, Takebayashi K, Inukai T. High serum high-sensitivity C-reactive protein concentrations are associated with relative cardiac sympathetic overactivity during the early morning period in type 2 diabetic patients with metabolic syndrome. Metabolism. 2006;55(8):1014-1021. 35. Murray DR, Prabhu SD, Chandrasekar B. Chronic beta-adrenergic stimulation induces myocardial proinflammatory cytokine expression. Circulation. 2000;101(20):2338-2341. 36. Freund C, Schmidt-Ullrich R, Baurand A, Dunger S, Schneider W, Loser P, El-Jamali A, Dietz R, Scheidereit C, Bergmann MW. Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo. Circulation. 2005;111(18):2319-2325. 37. Nakajima-Takenaka C, Sakata S, Kato S, Ohga Y, Murata KY, Taniguchi S, Takaki M. Detrimental effects after dobutamine infusion on rat left ventricular function: mechanical work and energetics. Exp Physiol. 2005;90(4):635-644. 38. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353(9169):2001-2007. 39. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 1999;353(9146):9-13. 40. Malliani A, Montano N. Emerging excitatory role of cardiovascular sympathetic afferents in pathophysiological conditions. Hypertension. 2002;39(1):63-68. 41. Minami M, Ishiyama A, Takagi M, Omata M, Atarashi K. Effects of allopurinol, a xanthine oxidase inhibitor, on renal injury in hypercholesterolemia-induced hypertensive rats. Blood Press. 2005;14(2):120-125. 42. Tao L, Liu HR, Gao E, Teng ZP, Lopez BL, Christopher TA, Ma XL, Batinic-Haberle I, Willette RN, Ohlstein EH, Yue TL. Antioxidative, antinitrative, and vasculoprotective effects of a peroxisome proliferator-activated receptor-gamma agonist in hypercholesterolemia. Circulation. 2003;108(22):2805-2811. 43. Luedtke NW, Hwang JS, Nava E, Gut D, Kol M, Tor Y. The DNA and RNA specificity of eilatin Ru(II) complexes as compared to eilatin and ethidium bromide. Nucleic Acids Res. 2003;31(19):5732-5740. 44. Tsang A, Hausenloy DJ, Yellon DM. Myocardial postconditioning: reperfusion injury revisited. Am J Physiol Heart Circ Physiol. 2005;289(1):H2-7. 45. Hool LC, Di Maria CA, Viola HM, Arthur PG. Role of NAD(P)H oxidase in the regulation of cardiac L-type Ca2+ channel function during acute hypoxia. Cardiovasc Res. 2005;67(4):624-635. 46. Zweier JL, Flaherty JT, Weisfeldt ML. Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci U S A. 1987;84(5):1404-1407. 47. Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS. Circulation. 2003;108(16):1912-1916. 48. Wanless IR, Belgiorno J, Huet PM. Hepatic sinusoidal fibrosis induced by cholesterol and stilbestrol in the rabbit: 1. Morphology and inhibition of fibrogenesis by dipyridamole. Hepatology. 1996;24(4):855-864. 49. Cathcart MK. Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages: contributions to atherosclerosis. Arterioscler Thromb Vasc Biol. 2004;24(1):23-28. 50. De Minicis S, Bataller R, Brenner DA. NADPH oxidase in the liver: defensive, offensive, or fibrogenic? Gastroenterology. 2006;131(1):272-275. 51. Kable EP, Kiemer AK. Non-invasive live-cell measurement of changes in macrophage NAD(P)H by two-photon microscopy. Immunol Lett. 2005;96(1):33-38. 52. Day CP, James OF. Steatohepatitis: a tale of two 'hits'? Gastroenterology. 1998;114(4):842-845. 53. Carmiel-Haggai M, Cederbaum AI, Nieto N. A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats. Faseb J. 2005;19(1):136-138. 54. Harada H, Hines IN, Flores S, Gao B, McCord J, Scheerens H, Grisham MB. Role of NADPH oxidase-derived superoxide in reduced size liver ischemia and reperfusion injury. Arch Biochem Biophys. 2004;423(1):103-108. 55. Bataller R, Schwabe RF, Choi YH, Yang L, Paik YH, Lindquist J, Qian T, Schoonhoven R, Hagedorn CH, Lemasters JJ, Brenner DA. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J Clin Invest. 2003;112(9):1383-1394. 56. Abdelrahman M, Mazzon E, Bauer M, Bauer I, Delbosc S, Cristol JP, Patel NS, Cuzzocrea S, Thiemermann C. Inhibitors of NADPH oxidase reduce the organ injury in hemorrhagic shock. Shock. 2005;23(2):107-114. 57. Pedruzzi E, Guichard C, Ollivier V, Driss F, Fay M, Prunet C, Marie JC, Pouzet C, Samadi M, Elbim C, O'Dowd Y, Bens M, Vandewalle A, Gougerot-Pocidalo MA, Lizard G, Ogier-Denis E. NAD(P)H oxidase Nox-4 mediates 7-ketocholesterol-induced endoplasmic reticulum stress and apoptosis in human aortic smooth muscle cells. Mol Cell Biol. 2004;24(24):10703-10717. 58. Feng B, Yao PM, Li Y, Devlin CM, Zhang D, Harding HP, Sweeney M, Rong JX, Kuriakose G, Fisher EA, Marks AR, Ron D, Tabas I. The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages. Nat Cell Biol. 2003;5(9):781-792. 59. Vilhardt F, van Deurs B. The phagocyte NADPH oxidase depends on cholesterol-enriched membrane microdomains for assembly. Embo J. 2004;23(4):739-748. 60. Mari M, Caballero F, Colell A, Morales A, Caballeria J, Fernandez A, Enrich C, Fernandez-Checa JC, Garcia-Ruiz C. Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis. Cell Metab. 2006;4(3):185-198. 61. Willner EL, Tow B, Buhman KK, Wilson M, Sanan DA, Rudel LL, Farese RV, Jr. Deficiency of acyl CoA:cholesterol acyltransferase 2 prevents atherosclerosis in apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A. 2003;100(3):1262-1267. 62. Lian X, Yan C, Yang L, Xu Y, Du H. Lysosomal acid lipase deficiency causes respiratory inflammation and destruction in the lung. Am J Physiol Lung Cell Mol Physiol. 2004;286(4):L801-807. 63. Cortez-Pinto H, de Moura MC, Day CP. Non-alcoholic steatohepatitis: from cell biology to clinical practice. J Hepatol. 2006;44(1):197-208. 64. Schneiderhan W, Schmid-Kotsas A, Zhao J, Grunert A, Nussler A, Weidenbach H, Menke A, Schmid RM, Adler G, Bachem MG. Oxidized low-density lipoproteins bind to the scavenger receptor, CD36, of hepatic stellate cells and stimulate extracellular matrix synthesis. Hepatology. 2001;34(4 Pt 1):729-737. 65. Ryu JW, Hong KH, Maeng JH, Kim JB, Ko J, Park JY, Lee KU, Hong MK, Park SW, Kim YH, Han KH. Overexpression of uncoupling protein 2 in THP1 monocytes inhibits beta2 integrin-mediated firm adhesion and transendothelial migration. Arterioscler Thromb Vasc Biol. 2004;24(5):864-870. 66. Kohl R, Preiss S, von Knethen A, Brune B. Oxidized low-density lipoprotein depletes PKCalpha and attenuates reactive oxygen species formation in monocytes/macrophages. Cardiovasc Res. 2006;71(3):574-585. 67. Yla-Herttuala S. Oxidized LDL and atherogenesis. Ann N Y Acad Sci. 1999;874:134-137. 68. Yang TL, Chen MF, Luo BL, Yu J, Jiang JL, Li YJ. Effect of fenofibrate on LDL-induced endothelial dysfunction in rats. Naunyn Schmiedebergs Arch Pharmacol. 2004;370(2):79-83. 69. Oguogho A, Ferlitsch A, Sinzinger H. LDL-apheresis decreases plasma levels and urinary excretion of 8-epi-PGF2alpha. Prostaglandins Leukot Essent Fatty Acids. 2000;62(4):209-216. 70. Korporaal SJ, Gorter G, van Rijn HJ, Akkerman JW. Effect of oxidation on the platelet-activating properties of low-density lipoprotein. Arterioscler Thromb Vasc Biol. 2005;25(4):867-872. 71. Locher R, Brandes RP, Vetter W, Barton M. Native LDL induces proliferation of human vascular smooth muscle cells via redox-mediated activation of ERK 1/2 mitogen-activated protein kinases. Hypertension. 2002;39(2 Pt 2):645-650. 72. Pritchard KA, Ackerman AW, Ou J, Curtis M, Smalley DM, Fontana JT, Stemerman MB, Sessa WC. Native low-density lipoprotein induces endothelial nitric oxide synthase dysfunction: role of heat shock protein 90 and caveolin-1. Free Radic Biol Med. 2002;33(1):52-62. 73. Stepp DW, Ou J, Ackerman AW, Welak S, Klick D, Pritchard KA, Jr. Native LDL and minimally oxidized LDL differentially regulate superoxide anion in vascular endothelium in situ. Am J Physiol Heart Circ Physiol. 2002;283(2):H750-759. 74. Granfeldt D, Samuelsson M, Karlsson A. Capacitative Ca2+ influx and activation of the neutrophil respiratory burst. Different regulation of plasma membrane- and granule-localized NADPH-oxidase. J Leukoc Biol. 2002;71(4):611-617. 75. Morimatsu T, Kawagoshi A, Yoshida K, Tamura M. Actin enhances the activation of human neutrophil NADPH oxidase in a cell-free system. Biochem Biophys Res Commun. 1997;230(1):206-210. 76. Europe-Finner GN, Newell PC. Inositol 1,4,5-trisphosphate and calcium stimulate actin polymerization in Dictyostelium discoideum. J Cell Sci. 1986;82:41-51. 77. Lochner JE, Badwey JA, Horn W, Karnovsky ML. all-trans-Retinal stimulates superoxide release and phospholipase C activity in neutrophils without significantly blocking protein kinase C. Proc Natl Acad Sci U S A. 1986;83(20):7673-7677. 78. Sasaki J, Hiura M, Yamaguchi M, Sakai M, Aoki K, Abe H, Okamura N, Ishibashi S. Activation mechanism of NADPH oxidase by SDS in intact guinea pig neutrophils. Arch Biochem Biophys. 1994;315(1):16-23. 79. Zhang WY, Schwartz E, Wang Y, Attrep J, Li Z, Reaven P. Elevated concentrations of nonesterified fatty acids increase monocyte expression of CD11b and adhesion to endothelial cells. Arterioscler Thromb Vasc Biol. 2006;26(3):514-519. 80. Islam KN, Devaraj S, Jialal I. alpha-Tocopherol enrichment of monocytes decreases agonist-induced adhesion to human endothelial cells. Circulation. 1998;98(21):2255-2261. 81. Kimura M, Kurose I, Russell J, Granger DN. Effects of fluvastatin on leukocyte-endothelial cell adhesion in hypercholesterolemic rats. Arterioscler Thromb Vasc Biol. 1997;17(8):1521-1526. 82. Sasaki M, Jordan P, Welbourne T, Minagar A, Joh T, Itoh M, Elrod JW, Alexander JS. Troglitazone, a PPAR-gamma activator prevents endothelial cell adhesion molecule expression and lymphocyte adhesion mediated by TNF-alpha. BMC Physiol. 2005;5(1):3. 83. Buga GM, Frank JS, Mottino GA, Hendizadeh M, Hakhamian A, Tillisch JH, Reddy ST, Navab M, Anantharamaiah GM, Ignarro LJ, Fogelman AM. D-4F decreases brain arteriole inflammation and improves cognitive performance in LDL receptor-null mice on a Western diet. J Lipid Res. 2006;47(10):2148-2160. 84. Lee HS, Jeong JY, Kim BC, Kim YS, Zhang YZ, Chung HK. Dietary antioxidant inhibits lipoprotein oxidation and renal injury in experimental focal segmental glomerulosclerosis. Kidney Int. 1997;51(4):1151-1159. 85. Parhami F, Tintut Y, Beamer WG, Gharavi N, Goodman W, Demer LL. Atherogenic high-fat diet reduces bone mineralization in mice. J Bone Miner Res. 2001;16(1):182-188. 86. Rajamannan NM, Subramaniam M, Stock SR, Stone NJ, Springett M, Ignatiev KI, McConnell JP, Singh RJ, Bonow RO, Spelsberg TC. Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve. Heart. 2005;91(6):806-810. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/30715 | - |
| dc.description.abstract | 高膽固醇血症為動脈粥狀硬化性疾病的主要危險因子,對人類健康形成重大威脅。目前盛行的理論認為在高膽固醇血症中,於內皮下空間累積的低密度脂蛋白可造成動脈血管壁的過氧化壓力及慢性發炎,因此減弱動脈對物理性或化學性刺激的抵禦,促成粥狀動脈硬化的起始與進展。由於動脈不是唯一暴露於低密度脂蛋白的組織,本論文提出假說,認為高膽固醇血症在動脈以外亦可能引發發炎現象而導致組織或器官的功能失常。
基於此一假設,本論文首先探討高膽固醇血症在心肌引發的發炎現象。在第二章中我們以十二周高膽固醇飲食於紐西蘭白兔誘發極度高膽固醇血症,並利用序列性磁振造影探討心肌功能性變化。我們發現在此模式中高膽固醇血症並不造成冠狀動脈阻塞以及心肌灌流缺失,也不影響左心室質量與射血分率,但心肌微循環滲漏性則顯著提升。此現象肇因於冠狀動脈系的血管新生,使心肌微循環內微血管表面積與單位面積滲漏性增加。我們同時也發現高膽固醇血症伴隨著血漿中磷脂醯膽鹼過氧化物(PCOOH)及IL-8的濃度上升,以及心肌遭巨噬細胞浸潤。以上因素都可能與冠狀動脈系的血管新生有關。雖然高膽固醇血症在兔心肌可能引起發炎現象,但此動物模式中過高的總膽固醇使得其結論的臨床相關性降低。因此我們在第三章中以三周高膽固醇飲食在大鼠引發溫和的高膽固醇血症,並分析在此模式中心臟功能的變化。研究結果發現高膽固醇血症在心肌可增加過氧化壓力,並引起巨噬細胞浸潤。針對生理功能的分析發現在此動物模式中微循環滲透性不受高膽固醇血症影響;心肌固有收縮力雖然下降,但左心室收縮反應增強,心跳增快,同時交感神經系統的活性亦顯著上升。以apocynin與ICAM-1單株抗體投與此等大鼠,心肌發炎與力學功能的交感神經過度活性可獲得改善。由以上證據,我們推測高膽固醇血症會經由過氧化壓力與發炎反應抑制心肌的固有收縮力,交感神經系統因而活化以為代償。有鑒於自由基與過氧化壓力在心臟病生理學的重要性,我們在第四章提出一套新穎技術,以dihydroethidium作為氧屬自由基的螢光探針,將高速螢光攝影術應用於離體灌流心臟,在活組織中記錄自由基隨生理/病理性刺激的改變。此系統可成功地偵測缺血再灌流過程中心肌內氧屬自由基的時序性變化。我們期待改進效能後此系統能應用於研究高膽固醇血症對心肌自由基動態的影響。 本論文的第五章著墨於高膽固醇血症在肝臟引發的發炎現象。肝臟是體內主要負責膽固醇代謝的器官,其生理配置使肝臟能負荷大量的膽固醇流量而不致引起細胞傷害,但高膽固醇血症是否可在肝臟誘發發炎則仍屬未知。以三周高膽固醇飲食誘發大鼠之高膽固醇血症後,我們發現血漿肝功能指數上升、門脈壓升高、肝組織纖維化與肝脾腫大。於組織切片中可發現肝實質中呈巨噬細胞浸潤並伴隨輕度門脈旁纖維化,進一步以二諧頻顯微術檢視活肝組織可發現其中的膠原蛋白結構在高膽固醇血症影響下出現顯著改變。肝組織之脂質分析顯示膽固醇主要以酯化型態累積於肝細胞中。利用活體雙光子顯微術測量活體動物中肝細胞自體螢光強度,我們發現高膽固醇血症大鼠的肝細胞中過氧化壓力呈顯著增加,同時此現象亦可由分析肝組織中TBARS與glutathione等過氧化壓力的生化指標得到證實。由於高膽固醇血症造成肝組織中gp91phox的表現增加,而且投與apocynin可逆轉高膽固醇血症引起的過氧化壓力及肝炎現象,故我們認為NADPH oxidase在高膽固醇血症造成脂肪性肝炎的病生理學中扮演重要角色。 本論文的第六章針對高膽固醇血症與血液中單核球活化的關係進行探討。由於前述研究發現高膽固醇血症引起心肌與肝臟中的巨噬細胞浸潤現象,而周邊循環中的單核球是組織發炎反應中巨噬細胞的主要來源,因此周邊循環單核球的活化可能是高膽固醇血症造成組織發炎的重要機轉。我們提出假說,認為在高膽固醇血症中過量的原型低密度脂蛋白在周邊循環中可直接活化單核球,引發過氧化壓力並促進單核球與內皮細胞的黏附,誘發微循環發炎現象。為驗證此假說,我們分離正常大鼠全血中的白血球,以原型與氧化型低密度脂蛋白刺激後觀察單核球細胞內過氧化壓力與表面黏附因子CD18之表現。研究發現原型低密度脂蛋白較氧化型低密度脂蛋白更能有效增加單核球細胞內氧化壓力,並發現細胞內鈣離子增加、肌動蛋白聚合以及NADPH oxidase活化均參與其訊息傳遞過程。同時原型低密度脂蛋白亦可增加單核球表面CD18的表現。此等現象可重現於高膽固醇大鼠體內,並且細胞內過氧化壓力以及過量的表面黏附因子促使白血球於提睪肌微循環中滾動、黏附與穿越,造成微循環發炎。Rosiglitazone除了用於治療第二型糖尿病,近年來亦發現具有強大抗發炎活性,故本實驗利用此發炎模式探討rosiglitazone的效果。我們發現rosiglitazone可透過影響肌動蛋白之聚合與NADPH oxidase的活性,降低原型低密度脂蛋白造成的單核球細胞內過氧化壓力。同時在高膽固醇大鼠口服投予rosiglitazone亦可改善高膽固醇血症引發的單核球活化與微循環發炎現象。以上結果顯示rosiglitazone可能對改善高膽固醇血症造成的微循環發炎性病變具有療效。 綜上所言,本論文發現低密度脂蛋白不需氧化修飾亦可活化周邊單核球,進而誘發提睪肌微循環的發炎反應,並利用兩種高膽固醇血症的動物模式,證明高膽固醇血症誘發的發炎反應不只侷限於動脈血管壁,亦可及於心肌及肝組織之微循環。這些研究顯示NADPH oxidase衍生的過氧化壓力在此機制中是重要的致病機轉,也有希望成為藥物治療的新穎標靶。慢性微循環發炎可能影響正常組織功能,並釋放促發炎因子,促進動脈硬化的進展。我們期待更多的轉譯性研究以釐清微循環發炎的病生理學以及臨床相關性。 | zh_TW |
| dc.description.abstract | Hypercholesterolemia (HC) is a major risk factor for atherosclerotic vascular diseases. Current theory emphasizes the role of low-density lipoprotein (LDL) since its subintimal accumulation results in oxidative stress and inflammation of the arterial wall, which predispose the vessel to atherogenesis upon various physical/chemical noxious stimuli. Considering the artery is not the only tissue exposed to excess LDL during HC, we propose a hypothesis that HC would induce tissue inflammation and disturb physiologic function outside the arterial wall.
We first targeted the heart to investigate this hypothesis with a rabbit model of HC. In this model, extreme HC was induced in New Zealand white rabbits by 12 weeks of 0.5% cholesterol-enriched diet. Left ventricular function and microcirculatory characteristics were determined with serial cardiac magnetic resonance imaging. We found that HC significantly enhanced microvascular leakage while regional perfusion, left ventricular mass, and ejection fraction were comparable to the control group. Morphologically there were increased macrophage infiltration and coronary neovascularization in the myocardium. Parallel increases in serum levels of phosphatidylcholine hydroperoxide (PCOOH) and IL-8 might provide a link between myocardial inflammation and angiogenesis. We also examined the effects of mild HC on cardiac function in a rat model. In this model, the rats were fed 4% cholesterol-enriched diet for 3 weeks, and oxidative stress as well as macrophage accumulation in the heart led to a totally different phenotype. While Evans blue leakage remained unchanged and intrinsic contractility was depressed, HC induced chronotropism, inotropism, and sympathetic hyperactivity of the rat heart. These phenomena were improved by systemic administration of either apocynin or intercellular adhesion molecule-1 (ICAM-1) neutralizing antibody. We concluded that oxidative stress and inflammation might depress contractile function in HC hearts, and as a result sympathetic activation ensues to maintain functional homeostasis. As it is important to understand the role of free radicals in cardiac pathophysiology, we developed an optical mapping system to detect reactive oxygen species in isolated perfused heart preparation. The system successfully recorded the dynamics of reactive oxygen species throughout global ischemia reperfusion. Adequate modification is necessary to apply the system in the research of free radicals in HC hearts. We next investigated HC-induced steatohepatitis. The liver experiences large flux of cholesterol everyday, but it is spared from cholesterol toxicity owing to effective esterification machinery and a tight control of cholesterol uptake. It is not clear, however, whether or not HC would overwhelm cholesterol-handling capability of the liver and induce steatohepatitis. In cholesterol-fed rats as mentioned above, the liver accumulated cholesteryl ester as well as triglycerides. We found elevated serum activities of alanine aminotransferase (ALT), aspartate transaminase (AST) and alkaline phosphatase (Alk-p), enhanced Evans blue extravasation, as well as increased macrophage infiltration; all indicated the presence of steatohepatitis. In addition we also found hepatosplenomegaly, portal hypertention and liver fibrosis in HC liver. Biochemical parameters such as tissue thiobarbituric acid-reactive substances (TBARS), glutathione (GSH) and GSSG (glutathione disulfide) as well as in vivo NADPH-derived autofluorescence indicated an increased oxidative burden in hepatocytes of HC rats. Since gp91phox was upregulated in HC livers and coadministration of apocynin effectively treated hepatic inflammation, NADPH oxidase must play a role in the pathogenesis of HC-induced steatohepatitis. In previous studies macrophages activation and infiltration were noted in the heart and the liver during HC. Since monocytes are the major source of inflammatory macrophages, we hypothesized that direct activation of monocytes by LDL in peripheral circulation contributes to HC-induced microvascular inflammation. We first demonstrated that both native- and copper oxidized- LDL elicited intracellular respiratory bursts in circulating monocytes in a time- and dose-dependent manner. In this experiment we found native LDL was a stronger stimulus, and subsequent studies showed that intracellular calcium mobilization, actin polymerization and NADPH oxidase activation were involved in the signaling pathway. Similar phenomena were observed in monocytes from HC rats, and augmented cellular oxidative stress as well as surface CD18 abundance resulted in increased leukocytes-endothelial interaction in cremaster microcirculation. Rosiglitazone as an insulin sensitizer and a potent anti-inflammatory agent was effective in treating HC-induced microvascular inflammation. It did so partly by reducing actin polymerization and NADPH oxidase activity in peripheral monocytes. To sum up, we provided experimental evidences in the heart and the liver to support our hypothesis that HC could induce inflammation and organ dysfunction beyond arterial atherosclerosis. We also proposed that native LDL activation of peripheral monocytes as one of the general pathogenic mechanism. As NADPH oxidase interwove these phenomena, it possibly will be an important target to develop novel therapeutic strategies. The clinical relevance of chronic microvascular inflammation remained obscure, and we are looking forwards to well-designed translational studies to unravel its significance. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-13T02:13:16Z (GMT). No. of bitstreams: 1 ntu-96-F89443002-1.pdf: 2317456 bytes, checksum: b1ba2d72f899786ce7e7fa26840f502d (MD5) Previous issue date: 2007 | en |
| dc.description.tableofcontents | 第一章 緒論
第一節 膽固醇代謝概觀 ------------------------------ 1 第二節 飲食膽固醇與高膽固醇血症的相關性 ------------ 3 第三節 高膽固醇血症、過氧化壓力與粥狀動脈硬化 ----- 4 第四節 高膽固醇血症與微循環發炎反應 --------------- 5 第二章 高膽固醇血症誘發白兔心肌發炎反應之探討 第一節 背景 --------------------------------------- 15 第二節 實驗方法與材料 ----------------------------- 15 第三節 結果 --------------------------------------- 18 第四節 討論 --------------------------------------- 20 第三章 高膽固醇血症誘發大鼠心肌發炎反應之探討 第一節 背景 --------------------------------------- 31 第二節 實驗方法與材料 ------------------------------ 31 第三節 結果 ---------------------------------------- 35 第四節 討論 ---------------------------------------- 37 第四章 應用高速螢光攝影術於離體灌流心肌之自由基偵測 第一節 背景 -------------------------------------- 53 第二節 實驗方法與材料 ------------------------------ 53 第三節 結果 -------------------------------------- 55 第四節 討論 -------------------------------------- 56 第五章 高膽固醇血症誘發非酒精性脂肪性肝炎之機制與治療 第一節 背景 -------------------------------------- 63 第二節 實驗方法與材料 ------------------------------ 63 第三節 結果 -------------------------------------- 67 第四節 討論 --------------------------------------- 69 第六章 高膽固醇血症誘發微循環發炎反應之機制與治療 第一節 背景 --------------------------------------- 83 第二節 實驗方法與材料 ------------------------------ 83 第三節 結果 ---------------------------------------- 85 第四節 討論 ---------------------------------------- 87 第七章 結論與展望 --------------------------------- 105 參考文獻 -------------------------------------------- 109 附錄:發表論文列表 ------------------------------------ 120 圖目錄 圖1-1 細胞的膽固醇恆定機制 ------------------------------------------------------- 8 圖1-2 脂蛋白代謝示意圖 ------------------------------------------------------------- 9 圖1-3 膽固醇在體內的動態分布模式 --------------------------------------------- 10 圖1-4 飲食膽固醇對血膽固醇濃度的影響 --------------------------------------- 11 圖1-5 白血球多步驟徵召假說 ------------------------------------------------------ 12 圖2-1 由動態顯影劑磁振造影計算左心室滲漏性 ------------------------------ 23 圖2-2 高膽固醇飲食對血漿脂質濃度的影響 ------------------------------------ 24 圖2-3 高膽固醇飲食對血漿促血管新生因子濃度的影響 --------------------- 26 圖2-4 高膽固醇飲食對心肌微血管密度的影響 --------------------------------- 27 圖2-5 高膽固醇血症使心肌遭巨噬細胞浸潤 ------------------------------------ 28 圖3-1 高膽固醇飲食對大鼠血漿脂質的影響 ------------------------------------ 41 圖3-2 高膽固醇飲食對大鼠心肌脂質組成之影響 -------------------- 42 圖3-3 高膽固醇飲食對大鼠心肌微循環滲漏性的影響 ---------------- 43 圖3-4 高膽固醇飲食對大鼠失血後心跳加速反應的影響 -------------- 44 圖3-5 高膽固醇飲食對Dobutamine催迫測試的影響 ----------------- 46 圖3-6 高膽固醇飲食改變心肌中3-nitrotyrosine及gp91phox的含量 ------- 48 圖3-7 高膽固醇飲食對心肌中ED1及ICAM-1表現量的影響---------------- 49 圖4-1 高速螢光攝影術之實驗設備 -------------------------------- 58 圖4-2 灌流液溫度對心肌自由基動態的影響 ------------------------------------ 59 圖4-3 離體再灌流過程中心肌自由基的時序性變化 ------------------ 60 圖4-4 離體再灌流過程中同時記錄左心室壓、心電圖與自由基動態 ------ 61 圖5-1 高膽固醇飲食對大鼠血脂質的影響 --------------------------------------- 71 圖5-2 高膽固醇飲食對大鼠肝臟脂質組成的影響 ------------------------------ 72 圖5-3 高膽固醇飲食對血漿肝功能指數的影響 --------------------------------- 73 圖5-4 高膽固醇飲食對大鼠肝臟微循環滲漏性的影響 ------------------------ 74 圖5-5 高膽固醇飲食造成肝組織中巨噬細胞浸潤 ------------------------------ 75 圖5-6 以雙光子顯微術測量高膽固醇飲食對活體肝細胞自體螢光的影響 -- 77 圖5-7 高膽固醇飲食對肝組織內TBARS、GSH與GSSG含量之影響 ------ 79 圖5-8 高膽固醇飲食可誘導肝組織中 gp91phox表現 --------------------------- 80 圖5-9 高膽固醇飲食造成大鼠肝脾腫大及門脈高壓 --------------------------- 81 圖5-10 以二諧頻顯微術及三色染色法評估肝組織纖維化 --------------------- 82 圖6-1 低密度脂蛋白對單核球細胞內氧屬自由基含量的劑量時間反應 --- 91 圖6-2 以抑制劑分析native LDL引發細胞內過氧化壓力的訊息傳導路徑 -- 93 圖6-3 Actin聚合與細胞內鈣離子在native LDL訊息路徑中的互動 ------- 95 圖6-4 Rosiglitazone對native LDL下游訊息事件的影響 ---------------------- 97 圖6-5 Rosiglitazone對大鼠血脂質的影響 ---------------------------------------- 99 圖6-6 高膽固醇飲食對提睪肌微循環中白血球與內皮細胞互動的影響 - 100 圖6-7 高膽固醇血症與rosiglitazone對白血球活化標記的影響 ------------ 102 圖6-8 高膽固醇血症與口服rosiglitazone對單核球actin聚合與細胞內鈣動態 的影響 ------------------------------------------------------------------------ 104 圖7-1 高膽固醇飲食誘發發炎反應之病生理學與藥物治療 --------- 108 表目錄 表1-1 造成高膽固醇血症的單基因缺陷 -------------------------------------------- 13 表1-2 黏附因子在白血球多步驟徵召假說中的角色 ----------------------------- 14 表2-1 以磁振造影評估左心室質量、力學功能及微循環滲漏性 ---------- 29 表3-1 以壓力容積關係分析高膽固醇飲食對大鼠左心室功能的影響 -- 50~51 表3-2 以心率變異性分析探討高膽固醇飲食對自律神經系統活性的影響 -- 52 | |
| dc.language.iso | zh-TW | |
| dc.title | 探討高膽固醇飲食誘發發炎反應之病生理學、藥物治療與新穎影像技術之應用 | zh_TW |
| dc.title | On Dietary Hypercholesterolemia-Induced Inflammation: Diagnosis, Pathophysiology and Treatment | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 95-2 | |
| dc.description.degree | 博士 | |
| dc.contributor.oralexamcommittee | 顏茂雄,林幸榮,陳明豐,林啟萬 | |
| dc.subject.keyword | 膽固醇,發炎,交感神經活性,非酒精性脂肪性肝炎,微循環,單核球,過氧化壓力,原型低密度脂蛋白, | zh_TW |
| dc.subject.keyword | cholesterol,inflammation,sympathetic activity,non-alcoholic steatohepatitis,microcirculation,monocytes,oxidative stress,native low-density lipoprotein, | en |
| dc.relation.page | 119 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2007-06-05 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 藥理學研究所 | zh_TW |
| 顯示於系所單位: | 藥理學科所 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-96-1.pdf 未授權公開取用 | 2.26 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
